Anti-angiogenesis Agents in Metastatic or Recurrent Cervical Cancer
Antiangiogenesis Agents in Metastatic or Recurrent Cervical Cancer
BJ Monk, LJ Willmott, DA Sumner
Yes
20100101
2010 Feb 1
Gynecol Oncol
Anti-angiogenesis Agents in Metastatic or Recurrent Cervical Cancer
Gynecol Oncol. 2010 Feb 1;116(2):181-186, BJ Monk, LJ Willmott, DA Sumner
Abstract
Abstract
While the incidence of cervical cancer has declined significantly in the United States, it still remains a serious American health threat. When detected early, cervical cancer is generally curable. Early lesions are treated surgically, and locally advanced lesions are managed with concurrent cisplatin chemotherapy and pelvic radiation. Metastatic disease or recurrent lesions not amenable to radical local excision or regional radiation are treated with palliative chemotherapy. Current chemotherapeutic...